Guidance and quality standards awaiting development | Guidance

Showing 231 to 240 of 360

Guidance and quality standards awaiting development
Title	Type
PLX-PAD for treating muscle injury after arthroplasty for hip fracture in people 60 to 90 years [ID3989]	Technology appraisal guidance
Point-of-care lipid tests for cardiovascular disease prevention in primary and community care	HealthTech guidance
Port Delivery Platform with ranibizumab for treating wet age-related macular degeneration [ID3983]	Technology appraisal guidance
Povorcitinib for treating non-segmental vitiligo [GID-TA12019]	Technology appraisal guidance
Povorcitinib for treating prurigo nodularis [GID-TA12018]	Technology appraisal guidance
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [ID6720]	Technology appraisal guidance
Pridopidine for treating Huntington's disease [ID6525]	Technology appraisal guidance
Pritelivir (AIC-316) for Herpes simplex virus 2 infection (HSV-2) [12367]	Technology appraisal guidance
Procalcitonin to guide decisions on stopping antibiotics in people with confirmed or highly suspected sepsis	HealthTech guidance
ProKnow cloud-based system for radiotherapy data storage, communication and management	HealthTech guidance